ClosedPublished 24 Apr 2026

Telomir Pharmaceuticals, Inc. /
TELI Pharmaceuticals, Inc.

Telomir completes purchase of TELI Pharmaceuticals

Buy side: Telomir Pharmaceuticals, Inc.
Buy sideTelomir Pharmaceuticals, Inc.
Target: TELI Pharmaceuticals, Inc.
TargetTELI Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. · 24 Apr 2026Source
Buy side: Telomir Pharmaceuticals, Inc.
Buy sideTelomir Pharmaceuticals, Inc.
Target: TELI Pharmaceuticals, Inc.
TargetTELI Pharmaceuticals, Inc.
01 / BuyerTelomir Pharmaceuticals, Inc.
02 / TargetTELI Pharmaceuticals, Inc.
Source for the buyer and target: Telomir Pharmaceuticals, Inc.

For the buyer and target.

“On April 22, 2026, Telomir Pharmaceuticals, Inc. (the “Company”) completed its acquisition of TELI Pharmaceuticals, Inc. (“TELI”) pursuant to the previously announced merger agreement (the “Transaction”).”

Published 24 Apr 2026

Open the source
01

What happened

Telomir Pharmaceuticals, Inc. has completed its acquisition of TELI Pharmaceuticals, Inc. under a previously announced merger agreement. At closing, TELI's former shareholders received 34,389,710 restricted shares of Telomir common stock, and the transaction consolidates worldwide rights to the Telomir-1 platform under a single corporate structure. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Telomir Pharmaceuticals, Inc.

Telomir completes purchase of TELI Pharmaceuticals

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Telomir Pharmaceuticals, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.